Phenylbutazone 200 MG/ML Injectable Solution [Equi-Phar]

Known as: Equi-Phar 200 MG/ML Injectable Solution, PHENYLBUTAZONE 200 mg in 1 mL INTRAVENOUS INJECTION [EQUI-PHAR] 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
Objectives: The monitoring system PHAR-MON (formerly: ebis-med) documents the misuse of pharmaceuticals in addiction counseling… Expand
Is this relevant?
2008
2008
Literature has widely acknowledged that creating a tight network of collaborati ons is an unavoidable strategy for innovative… Expand
Is this relevant?
2007
2007
Americans made 1.17 billion visits to ambulatory clinics and emergency departments in 2005. Acute respiratory infections (i.e… Expand
Is this relevant?
2005
2005
Received 23 November 2004; accepted 23 November 2004; electronically published 22 March 2005. Reprints or correspondence: Dr… Expand
Is this relevant?
2001
2001
Opinion statement|Mechanical measures such as graduated compression stockings and intermittent compression boots are available… Expand
Is this relevant?
1999
1999
AbstractObjective: The aim of the present study is to describe a refinement of a previously presented method, based on the… Expand
  • figure 1
  • table I
  • table II
  • figure 2
  • table III
Is this relevant?
1997
1997
SummaryThe level of uncertainty with regard to the outcomes of pharmacoeconomic studies cannot be completely covered by the… Expand
  • figure 1
  • table I
  • figure 2
  • table II
  • figure 4
Is this relevant?
1985
1985
Throughout the history of the development and use of medical technologies (phar-maceuticals, laboratory tests, invasive and… Expand
Is this relevant?
1977
1977
Summary Valproic acid (VPA) and ethosuximide (ESM) were administered by intravenous infusion at a constant rate to 12… Expand
Is this relevant?